OISIN BIOTECHNOLOGIES
Oisin Biotechnologies is a platform drug development company focused on creating drugs to combat a variety of age-related diseases. It is developing a highly precise, patent-pending, DNA-targeted intervention to clear these cells. As a recent study has shown, clearing senescent cells both reduces the negative effects of aging pathologies and also extends the median lifespan and survival. Oisin Biotechnologies was founded in 2014 and is headquartered in Seattle, Washington.
OISIN BIOTECHNOLOGIES
Social Links:
Industry:
Biopharma Biotechnology Medical
Founded:
2014-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.oisinbio.com
Total Employee:
11+
Status:
Active
Contact:
206-880-1166
Total Funding:
7.12 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Tag Manager Content Delivery Network Global Site Tag JQuery CDN Typekit Squarespace
Similar Organizations
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Rainier Therapeutics
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Employees Featured
Founder
Investors List
Althea Ventures
Althea Ventures investment in Seed Round - Oisin Biotechnologies
Benjamin Kong
Benjamin Kong investment in Seed Round - Oisin Biotechnologies
Kingsley Advani
Kingsley Advani investment in Seed Round - Oisin Biotechnologies
Avant Global
Avant Global investment in Seed Round - Oisin Biotechnologies
Hedgewood
Hedgewood investment in Seed Round - Oisin Biotechnologies
KIZOO Technology Capital
KIZOO Technology Capital investment in Seed Round - Oisin Biotechnologies
Newest Events participated
Official Site Inspections
http://www.oisinbio.com
- Host name: 198.185.159.144
- IP address: 198.185.159.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Oisin Biotechnologies"
Oisín Biotechnologies
Oisín has a robust pipeline targeting multiple drivers of age-related conditions. We have programs that target frailty by stimulating muscle growth, selectively kill fat cells, and remove senescent cells.See details»
Oisin Biotechnologies - Crunchbase Company Profile
Oisin Biotechnologies is a platform drug development company focused on creating drugs to combat a variety of age-related diseases. It is developing a …See details»
Executive Team - Oisín Biotechnologies
Oisín Biotechnologies. 701 Fifth Avenue Suite 4200 Seattle, WA 98104See details»
Team - Oisín Biotechnologies
Oisín Biotechnologies. 701 Fifth Avenue Suite 4200 Seattle, WA 98104See details»
Oisin Biotechnologies - LinkedIn
Oisin Biotechnologies is a longevity therapeutics platform company focused on creating genetic medicines to combat a variety of age related diseases.See details»
Oisín Biotechnologies Announces First Close of $15 …
SEATTLE, July 24, 2024--Oisín Biotechnologies (Oisín), a privately held biotechnology company focused on mitigating the effects of age-related diseases, today announced the first close in a $15 ...See details»
Oisin Biotechnologies - Craft
Oisin Biotechnologies has 5 employees across 2 locations and $5 m in total funding,. See insights on Oisin Biotechnologies including office locations, competitors, revenue, financials, …See details»
Oisin Biotechnologies Company Overview, Contact Details
May 27, 2021 [email protected]: [email protected]: 6%. See more formats. Frequently Asked Questions Where is Oisin Biotechnologies 's headquarters located? Oisin …See details»
Oisin Biotechnologies - VentureRadar
"Oisín Biotechnologies' ground-breaking research and technology is demonstrating that the solution to mitigating the effects of age-related diseases is to address the damage created by …See details»
Oisín Biotechnologies Announces Publication of Preclinical Data …
SEATTLE, September 10, 2024--Oisín Biotechnologies (Oisín), a privately held biotechnology company focused on mitigating the effects of age-related diseases, today announced the …See details»
Oisín Biotechnologies Announces First Close of $15 Million Series …
The company’s first therapies focus on eliminating unwanted fat cells and building muscle mass. For more information, visit www.oisinbio.com or follow Oisín on X and LinkedIn. About AbbVie …See details»
Oisín Announces $5 Million in New Seed Funding | Lifespan.io
May 27, 2021 For more information, visit www.oisinbio.com. We would like to ask you a small favor. We are a non-profit foundation, and unlike some other organizations, ... Lifespan …See details»
An Update on the Work of Oisin Biotechnologies: Building …
Jun 5, 2017 Oisin Biotechnologies is a creation of our core community of longevity advocates, researchers, philanthropists, and others. The present CEO, Gary Hudson, was one of the first …See details»
Oisin Biotechnologies raises $5M seed round - Longevity List
May 27, 2021 Oisín is a late preclinical stage company developing therapeutics to reduce the effects of the aging process. Headquartered in Seattle, Washington, the company’s first …See details»
Oisín Biotechnologies Announces Publication of Preclinical Data …
Sep 11, 2024 For more information, visit www.oisinbio.com or follow Oisín on X and LinkedIn. About Entos Pharmaceuticals Inc. A new reality in genetic medicine lies ahead, one that will …See details»
Oisín Biotechnologies Raises Seed Funding to Advance
May 27, 2021 SEATTLE--(BUSINESS WIRE)--Oisín Biotechnologies, a privately held, preclinical biotechnology company focused on mitigating the effects of age-related diseases, today …See details»
Oisín Biotechnologies Included in - Business Wire
Feb 26, 2020 Oisín Biotechnologies, a privately held, preclinical biotechnology company focused on mitigating the effects of age-related diseases, today announcedSee details»
Oisín Biotechnologies Announces Publication of Preclinical Data …
Sep 10, 2024 For more information, visit www.oisinbio.com or follow Oisín on X and LinkedIn. About Entos Pharmaceuticals Inc. A new reality in genetic medicine lies ahead, one that will …See details»
Developing Genetic Medicines for Health and Longevity
Www.oisinbio.com Market Opportunity Management Team Past: Oisín has successfully raised over $11.2 million to date through SAFEs and a seed round. Present: Oisín is seeking a $15 …See details»
OISÍN BIOTECHNOLOGIES RAISES SEED FUNDING TO ADVANCE …
Visit www.oisinbio.com. # # # Title: Microsoft Word - 21.05.24 Oisin funding announcement v2.docx Created Date: 5/25/2021 5:11:22 PM ...See details»